ARS Pharmaceuticals (SPRY) EBT Margin (2022 - 2026)
ARS Pharmaceuticals' EBT Margin was -182.62% in Q2 2026, up 120.33 percentage points from -302.95% a year earlier and up 82.56 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) EBT Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, ARS Pharmaceuticals' EBT Margin was -184.96% through Jun 30, 2026, down 132.13 percentage points year-over-year; for FY2025, it came in at -203.35%, down 212.64 percentage points from FY2024.
- EBT Margin shows a four-year change of +149.98 percentage points (FY2021 to FY2025).
- In earlier years, EBT Margin was 9.29% in FY2024 (+181225.96 pp), -181216.67% in FY2023 (-178517.88 pp), -2698.78% in FY2022 (-2345.46 pp) and -353.32% in FY2021.
- Quarterly EBT Margin has moved between -206030.00% (Q2 2023) and 54.51% (Q4 2024) over five years.
- Compared with a year earlier, EBT Margin was higher in four of the last five quarters, with an average year-over-year change of +754.47 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q2 2024 (a gain of 202962.00 percentage points); the worst was Q2 2023 (a drop of 204662.76 percentage points).
- Per Business Quant data, SPRY's EBT Margin in the three quarters before Q2 2026 was -265.18% (Q1 2026), -147.63% (Q4 2025) and -163.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | -182.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -182.62% |
| Mar 31, 2026 | -265.18% |
| Dec 31, 2025 | -147.63% |
| Sep 30, 2025 | -163.66% |
| Jun 30, 2025 | -302.95% |
| Mar 31, 2025 | -466.29% |
| Dec 31, 2024 | 54.51% |
| Sep 30, 2024 | -1,051.64% |
| Jun 30, 2024 | -3,068.00% |
| Jun 30, 2023 | -206,030.00% |
| Mar 31, 2023 | -93,565.00% |
| Sep 30, 2022 | -3,507.94% |
| Jun 30, 2022 | -1,367.24% |
| Mar 31, 2022 | -1,070.74% |
API Access
ARS Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();